Meikang Biology: Obtained medical device registration certificate.

Meikang Biological announces that the company recently obtained the "Medical Device Registration Certificate of the People's Republic of China" issued by the Zhejiang Provincial Drug Administration. This includes quality control products for Camazepam and Valproic Acid, with registration certificate numbers Zhejiang Medical Standard 20252401345 and Zhejiang Medical Standard 20252401346, respectively. The validity period is from May 7, 2025 to May 6, 2030. The acquisition of the above-mentioned "Registration Certificate" enriches the company's product line in the field of mass spectrometry in vitro diagnostics, which is conducive to further enhancing the company's core competitiveness and market expansion capabilities.